Days after her name appeared in a tranche of newly released Jeffrey Epstein emails, Goldman Sachs General Counsel Kathy Ruemmler sent a company-wide message that some bank employees found tone-deaf. D...
A closer look at the Tom Sachs x NikeCraft General Purpose Participation Shoe, an exclusive release for Mars Yard 3.0 raffle losers. The Tom Sachs x NikeCraft General Purpose Participation Shoe has a ...
A closer look at the Tom Sachs x NikeCraft General Purpose Participation Shoe, an exclusive release for Mars Yard 3.0 raffle losers. The Tom Sachs x NikeCraft General Purpose Participation Shoe has a ...
A closer look at the Tom Sachs x NikeCraft General Purpose Participation Shoe, an exclusive release for Mars Yard 3.0 raffle losers. The Tom Sachs x NikeCraft General Purpose Participation Shoe has a ...
A closer look at the Tom Sachs x NikeCraft General Purpose Participation Shoe, an exclusive release for Mars Yard 3.0 raffle losers. The Tom Sachs x NikeCraft General Purpose Participation Shoe has a ...
Goldman Sachs defends top lawyer Kathy Ruemmler after controversial emails with Jeffrey Epstein surface. Goldman Sachs on Thursday firmly supported its top lawyer, Kathryn “Kathy” Ruemmler...
Fiserv (FI) was trading lower as Morgan Stanley and Goldman Sachs cut their recommendation on the stock to Hold-equivalent after the payment technology company’s Q3 earnings release. Fiserv down...
The healthcare revenue management company wants to sell or IPO at $13 billion, and will go to market early next year, sources told Business Insider. Ensemble Health, a major player in healthcare reven...
US News is a recognized leader in college, grad school, hospital, mutual fund, and car rankings. Track elected officials, research health conditions, and find news you can use in politics, business, h...
Celestica (CLS) was in focus on Thursday as Goldman Sachs initiated coverage on the Canadian technology company with a Buy rating and $340 price target. Read for more. Celestica rises as Goldman Sachs...
